Evidence mapPaperPMID 37111101Full record

ArticleNutrients2023

Antidiabetic Activity of Potential Probiotics

Chandana Kumari V B, Sujay S Huligere, Ghallab Alotaibi, Abdulaziz K Al Mouslem, Ammar Abdulraheem Bahauddin, Thippeswamy Boreddy Shivanandappa, Ramith Ramu

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Frontiers in veterinary science · 2025
    Article
  6. Article
  7. Article
  8. Cell-free supernatant ofFrontiers in microbiology · 2024
    Article
  9. Fermented sugarcane juice-derived probioticFrontiers in microbiology · 2024
    Article
  10. Review
  11. Isolation andFrontiers in microbiology · 2024
    Article
  12. Review
  13. Nutritional Interventions withInternational journal of molecular sciences · 2023
    Article
  14. Article
  15. Screening for potential novel probioticFrontiers in microbiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Chandana Kumari V BDepartment of Biotechnology and Bioinformatics, JSS Academy of Higher Education and Research, Mysuru 570015, Karnataka, India.ORCID 0000-0003-1806-8452
Sujay S HuligereDepartment of Biotechnology and Bioinformatics, JSS Academy of Higher Education and Research, Mysuru 570015, Karnataka, India.ORCID 0000-0002-8954-7509
Ghallab AlotaibiDepartment of Pharmaceutical Sciences, College of Pharmacy, Shaqra University, Al-Dawadmi Campus, Shaqra 11961, Saudi Arabia.
Abdulaziz K Al MouslemDepartment of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al Ahsa 31982, Saudi Arabia.ORCID 0000-0002-3868-2057
Ammar Abdulraheem BahauddinDepartment of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Madinah 42535, Saudi Arabia.
Thippeswamy Boreddy ShivanandappaDepartment of Biomedical Science, College of Pharmacy, Shaqra University, Al-Dawadmi Campus, Shaqra 11961, Saudi Arabia.ORCID 0000-0001-9960-2498
Ramith RamuDepartment of Biotechnology and Bioinformatics, JSS Academy of Higher Education and Research, Mysuru 570015, Karnataka, India.
JSS Academy of Higher Education and Research · INShaqra University · SAKing Faisal University · SATaibah University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Probiotics are regarded as a potential source of functional foods for improving the microbiota in human gut. When consumed, these bacteria can control the metabolism of biomolecules, which has numerous positive effects on health. Our objective was to identify a probiotic putative

Indexed as

ProbioticsSaccharumalpha-Amylasesalpha-GlucosidasesCitratesHumansHypoglycemic AgentsLacticaseibacillusRNA, Ribosomal, 16Salpha-Amylasesalpha-GlucosidasesCitrateshydroxycitric acidHypoglycemic AgentsRNA, Ribosomal, 16Slactic acid bacteriaprobioticsugarcaneα-amylaseα-glucosidase

Identifiers

PMID37111101
PMCPMC10144524
OpenAlexW4365516702

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.